Concord Biotech Limited (BOM:543960)
India · Delayed Price · Currency is INR 1,420.30
+87.10 (6.53%)
At close: Jul 31, 2026
Concord Biotech Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 11,084 | 10,549 | 12,001 | 10,169 | 8,532 | 7,129 |
Revenue Growth | -6.72% | -12.10% | 18.01% | 19.20% | 19.67% | 15.56% |
Gross Profit Gross Profit Growth | 7,156 | 6,766 | 7,684 | 6,672 | 6,611 | 5,410 |
Operating Income Operating Income Growth | 3,250 | 3,043 | 4,628 | 3,868 | 2,999 | 2,290 |
Net Income Net Income Growth | 2,754 | 2,609 | 3,716 | 3,081 | 2,401 | 1,749 |
Earnings Per Share EPS Growth | 26.24 | 24.94 | 35.52 | 29.45 | 22.95 | 16.72 |
EPS Growth | -22.90% | -29.80% | 20.62% | 28.33% | 37.25% | -25.52% |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 5,636 | 6,618 | 5,342 | 4,321 | 3,392 |
America America Growth | 1,080 | 1,380 | 1,080 | 1,473 | 1,315 |
Others Others Growth | 3,833 | 4,003 | 3,747 | 2,738 | 2,423 |
Total Total Growth | 10,549 | 12,001 | 10,169 | 8,532 | 7,129 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 4,319 | 4,319 | 3,354 | 2,817 | 1,710 | 1,614 |
Total Debt Total Debt Growth | 23.16 | 23.16 | 29.69 | 97.38 | 315.46 | 624.93 |
Net Cash (Debt) Net Cash Growth | 4,296 | 4,296 | 3,325 | 2,719 | 1,395 | 988.98 |
Net Cash Growth | 36.48% | 29.20% | 22.26% | 94.98% | 41.02% | -11.58% |
Net Cash Per Share Net Cash Per Share Growth | 40.93 | 41.06 | 31.78 | 25.99 | 13.33 | 9.45 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 2,669 | 2,445 | 2,655 | 2,460 | 2,081 |
Capital Expenditures CapEx Growth | - | -951.51 | -1,112 | -856.89 | -1,451 | -1,555 |
Free Cash Flow Free Cash Flow Growth | - | 1,717 | 1,333 | 1,798 | 1,009 | 526.36 |
Free Cash Flow Growth | - | 28.79% | -25.83% | 78.14% | 91.72% | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 64.56% | 64.14% | 64.03% | 65.61% | 77.49% | 75.89% |
Operating Margin | 29.32% | 28.85% | 38.57% | 38.03% | 35.15% | 32.12% |
Pretax Margin | 32.86% | 32.67% | 41.21% | 40.57% | 37.74% | 33.32% |
Profit Margin | 24.84% | 24.73% | 30.97% | 30.30% | 28.14% | 24.54% |
FCF Margin | - | 16.28% | 11.11% | 17.68% | 11.83% | 7.38% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 18.250 | 7.550 | 10.700 | 8.750 | 6.830 | 5.120 |
Dividend Per Share Growth | 0% | -29.44% | 22.29% | 28.11% | 33.40% | -24.05% |
Dividend Yield | 1.37% | 0.75% | 0.65% | 0.58% | - | - |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 53.98 | 40.84 | 47.31 | 51.64 | - | - |
P/FCF Ratio | 86.55 | 62.04 | 131.85 | 88.50 | - | - |
PS Ratio | 13.41 | 10.10 | 14.65 | 15.65 | - | - |